Olink Holding AB (OLK)
25.58
+0.08
(+0.31%)
USD |
NASDAQ |
Jun 20, 11:09
Olink Net Income (TTM): -33.70M for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -33.70M |
| December 31, 2023 | -31.60M |
| September 30, 2023 | -18.62M |
| June 30, 2023 | -18.09M |
| March 31, 2023 | -14.64M |
| December 31, 2022 | -12.85M |
| September 30, 2022 | -26.25M |
| Date | Value |
|---|---|
| June 30, 2022 | -30.44M |
| March 31, 2022 | -36.21M |
| December 31, 2021 | -38.34M |
| September 30, 2021 | -23.88M |
| June 30, 2021 | -18.51M |
| March 31, 2021 | -9.957M |
| December 31, 2020 | -6.78M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-38.34M
Minimum
Dec 2021
-6.78M
Maximum
Dec 2020
-22.85M
Average
-21.25M
Median
Net Income (TTM) Benchmarks
| Abliva AB | -9.205M |
| Karolinska Development AB | 3.171M |
| Calliditas Therapeutics AB | -49.82M |
| Oncopeptides AB | -24.46M |
| BioInvent International AB | -31.66M |